131 related articles for article (PubMed ID: 25199771)
1. Clinical characteristics and pathogenesis of cerebellar glioblastoma.
Takahashi Y; Makino K; Nakamura H; Hide T; Yano S; Kamada H; Kuratsu J
Mol Med Rep; 2014 Nov; 10(5):2383-8. PubMed ID: 25199771
[TBL] [Abstract][Full Text] [Related]
2. Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma.
Utsuki S; Oka H; Miyajima Y; Kijima C; Yasui Y; Fujii K
Brain Tumor Pathol; 2012 Apr; 29(2):87-95. PubMed ID: 22076316
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of primary cerebellar glioblastoma multiforme in adults.
Gopalakrishnan CV; Dhakoji A; Nair S; Menon G; Neelima R
J Clin Neurosci; 2012 Dec; 19(12):1684-8. PubMed ID: 23084346
[TBL] [Abstract][Full Text] [Related]
4. Cystic glioblastoma: an evaluation of IDH1 status and prognosis.
Sarmiento JM; Nuño M; Ortega A; Mukherjee D; Fan X; Black KL; Patil CG
Neurosurgery; 2014 Jan; 74(1):71-5: discussion 75-6. PubMed ID: 24089051
[TBL] [Abstract][Full Text] [Related]
5. IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.
Kalkan R; Atli Eİ; Özdemir M; Çiftçi E; Aydin HE; Artan S; Arslantaş A
Gene; 2015 Jan; 554(1):81-6. PubMed ID: 25455102
[TBL] [Abstract][Full Text] [Related]
6. Characterization of molecular genetic alterations in GBMs highlights a distinctive molecular profile in young adults.
Jha P; Suri V; Singh G; Jha P; Purkait S; Pathak P; Sharma V; Sharma MC; Suri A; Gupta D; Mahapatra AK; Sarkar C
Diagn Mol Pathol; 2011 Dec; 20(4):225-32. PubMed ID: 22089350
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas.
Saito T; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Arifin MT; Arita K; Kurisu K
Anticancer Res; 2006; 26(2B):1351-7. PubMed ID: 16619544
[TBL] [Abstract][Full Text] [Related]
8. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.
Cho HJ; Zhao J; Jung SW; Ladewig E; Kong DS; Suh YL; Lee Y; Kim D; Ahn SH; Bordyuh M; Kang HJ; Sa JK; Seo YJ; Kim ST; Lim DH; Dho YS; Lee JI; Seol HJ; Choi JW; Park WY; Park CK; Rabadan R; Nam DH
Neuro Oncol; 2019 Jan; 21(1):47-58. PubMed ID: 30085274
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
10. Outcome and prognostic factors in adult cerebellar glioblastoma.
Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in cerebellar glioblastoma multiforme. Case report.
Hernandez-Gonzalez G; Marchione P; De Angelis F; Giannone C; Kouleridou A; Spallone A
J Neurosurg Sci; 2012 Dec; 56(4):379-81. PubMed ID: 23111300
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.
Kraus JA; Felsberg J; Tonn JC; Reifenberger G; Pietsch T
Neuropathol Appl Neurobiol; 2002 Aug; 28(4):325-33. PubMed ID: 12175345
[TBL] [Abstract][Full Text] [Related]
13. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
Nobusawa S; Watanabe T; Kleihues P; Ohgaki H
Clin Cancer Res; 2009 Oct; 15(19):6002-7. PubMed ID: 19755387
[TBL] [Abstract][Full Text] [Related]
14. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme.
Shinojima N; Kochi M; Hamada J; Nakamura H; Yano S; Makino K; Tsuiki H; Tada K; Kuratsu J; Ishimaru Y; Ushio Y
J Neurosurg; 2004 Aug; 101(2):219-26. PubMed ID: 15309911
[TBL] [Abstract][Full Text] [Related]
15. Genetic characterization of gliomas arising in patients with multiple sclerosis.
Khalil A; Serracino H; Damek DM; Ney D; Lillehei KO; Kleinschmidt-DeMasters BK
J Neurooncol; 2012 Sep; 109(2):261-72. PubMed ID: 22547311
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and molecular analysis of primary glioblastomas in Moroccan patients.
Hilmani S; Abidi O; Benrahma H; Karkouri M; Sahraoui S; El Azhari A; Barakat A
J Mol Neurosci; 2013 Mar; 49(3):567-73. PubMed ID: 22865003
[TBL] [Abstract][Full Text] [Related]
17. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
18. A simplified approach for molecular classification of glioblastomas (GBMs): experience from a tertiary care center in India.
Purkait S; Mallick S; Sharma V; Kumar A; Pathak P; Jha P; Biswas A; Julka PK; Gupta D; Suri A; Upadhyay AD; Suri V; Sharma MC; Sarkar C
Brain Tumor Pathol; 2016 Jul; 33(3):183-90. PubMed ID: 26865311
[TBL] [Abstract][Full Text] [Related]
19. Massive dissemination of adult glioblastomas.
Willard N; Kleinschmidt-DeMasters BK
Clin Neuropathol; 2015; 34(6):330-42. PubMed ID: 26308254
[TBL] [Abstract][Full Text] [Related]
20. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis.
Jeswani S; Nuño M; Folkerts V; Mukherjee D; Black KL; Patil CG
Neurosurgery; 2013 Aug; 73(2):240-6; discussion 246; quiz 246. PubMed ID: 23615082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
